These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development. Castelino FV; Varga J Expert Rev Clin Immunol; 2013 Nov; 9(11):1077-90. PubMed ID: 24168414 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels. Smeets RL; Kersten BE; Joosten I; Kaffa C; Alkema W; Koenen HJPM; Vonk MC Autoimmun Rev; 2020 May; 19(5):102515. PubMed ID: 32173517 [TBL] [Abstract][Full Text] [Related]
11. An update on biomarker discovery and use in systemic sclerosis. Matsushita T; Takehara K Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919 [TBL] [Abstract][Full Text] [Related]
13. Systematic approach to understanding the pathogenesis of systemic sclerosis. Zuo X; Zhang L; Luo H; Li Y; Zhu H Clin Genet; 2017 Oct; 92(4):365-371. PubMed ID: 27918067 [TBL] [Abstract][Full Text] [Related]
14. Personalized medicine in systemic sclerosis: facts and promises. Dobrota R; Mihai C; Distler O Curr Rheumatol Rep; 2014 Jun; 16(6):425. PubMed ID: 24752884 [TBL] [Abstract][Full Text] [Related]
15. Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice? Vonk MC; Assassi S; Hoffmann-Vold AM Rheum Dis Clin North Am; 2023 May; 49(2):249-262. PubMed ID: 37028833 [TBL] [Abstract][Full Text] [Related]
16. Biomarkers in Scleroderma: Progressing from Association to Clinical Utility. Ligon C; Hummers LK Curr Rheumatol Rep; 2016 Mar; 18(3):17. PubMed ID: 26970773 [TBL] [Abstract][Full Text] [Related]